Cannabidiol

New tox study validates safe upper dose for cbdMD’s Broad Spectrum CBD blend

25-Sep-2023 By Stephen Daniells

cbdMD's proprietary broad spectrum blend is safe when consumed as a dietary supplement in doses up to 160 mg per day in a 70 kg (154 lb), says a new study published in Regulatory Toxicology and Pharmacology.

First-of-its-kind clinical trial supports CBD’s efficacy to boost sleep quality

13-Jun-2023 By Stephen Daniells

Four weeks of CBD (cannabidiol) supplementation at 15 mg per day led to clinically important improvement in their sleep quality, performing to a similar level to 5mg as melatonin, says a new study.

'Quite frankly, I'm concerned for our entire industry...' FDA cracks down on firms selling CBD-infused foods & beverages in ‘aggressive’ new stance

22-Nov-2022 By Elaine Watson

The FDA has sent out a raft of warning letters to brands selling CBD-infused foods and beverages, adopting an “aggressive position” that one industry source told us made him “concerned for our entire industry.”

SPECIAL REPORT: Hemp-derived CBD… ‘We're operating in a constrained addressable market with a patchwork of state-based regulations’

02-Sep-2022 By Elaine Watson

“I see all these emails going around saying once the [2018] Farm Bill passes, CBD is legal in all 50 states… and that’s just not true,” observed one attorney in December 2018. Four years later, while a lot has changed, the FDA maintains that CBD is not...

AHPA’s updated Hemp Lexicon seeks to shed light on ‘full spectrum’ question

25-Aug-2022 By Hank Schultz

The American Herbal Products Association has released a new guidance document that seeks to bring clarity to hemp nomenclature, in particular what ought to be meant by the terms ‘broad spectrum’ and ‘full spectrum’ extracts.

Provisions of Senate bill could decimate hemp industry, industry group asserts

10-Aug-2022 By Hank Schultz

Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.

Parliamentary group divided on proposals for new CBD approval system

29-Jun-2022 By Nicola Gordon-Seymour

Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.

NutraWomen Wednesday: Paola Fernandez, Founder and CEO of High Hemp

25-May-2022 By Danielle Masterson

While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...

FDA progress report on CBD ‘nothing more than an end-of-Administration desk-clearing exercise,’ says CRN

11-Jan-2021 By Elaine Watson

For food & supplement brands hoping 2021 might be the year the FDA unveils a long-awaited regulatory framework for CBD, its Jan 7 progress report citing the need for more safety data does not provide much encouragement, with the Council for Responsible...

UK Food Standards Agency issues industry deadline for CBD authentication

13-Feb-2020 By Will Chu

Cannabidiol (CBD) industry groups have welcomed new regulatory and precautionary advice by UK authorities highlighting its “clear trajectory towards developing a safe and legally compliant CBD industry.”

FDA asks for $5 million for CBD initiatives; industry groups cautiously in favor

12-Feb-2020 By Hank Schultz

A $5 million FDA budget request earmarked for CBD initiatives has garnered the cautious support of dietary supplement stakeholders.

Warning letter analysis shows FDA has target on CBD, not hemp

16-Jan-2020 By Hank Schultz

An analysis of recent warning letters underscores the notion that FDA is focused its enforcement efforts on CBD, and is not targeting hemp extracts per se.

CBD and turmeric absorption: Holista Colltech files for delivery system global patent

13-Jan-2020 By Guan Yu Lim

Holista CollTech has filed for a global patent for its water-soluble delivery system, which it claims makes fat-soluble molecules such as cannabidiol (CBD) more readily absorbed by the body.

“Recreational Marijuana and CBD: Public Attitudes, Science, and the Law” overview

04-Dec-2019 By Danielle Masterson

The Harvard School of Public Health and Politico jointly presented a live webcast that focused on the evolving landscape of cannabinoids.

Editor's Spotlight: Notes from Nutrition 2019 in Baltimore, June 8-11

How the CBD, hemp, and cannabis conversation is playing out among nutritionists

12-Jun-2019 By Adi Menayang

Is there a role for cannabis and its derivatives to play in our food system, perhaps as part of a healthy, well-balanced diet? Scientists explored the question at the recent Nutrition 2019 conference in Baltimore.

Hemp market’s rapid evolution complicates business planning, expo attendees told

02-Apr-2019 By Hank Schultz

The hemp industry is advancing so rapidly that the timeline of decades of other sectors is being compressed into just years, attendees at a recent trade show were told.

'Ignorance is amok... not even the investors are asking the right questions. It’s total anarchy'

SPECIAL FEATURE: What is the regulatory status of CBD in food and beverage products?

11-Oct-2018 By Elaine Watson

If you ask the FDA or the DEA if CBD (cannabidiol) is permitted in foods, beverages and supplements, the answer is a pretty unequivocal NO. If you ask the scores of companies currently selling it in everything from CBD-infused soda to smoothie kits, the...